SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 12, 1998
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission (IRS EMPLOYER
or incorporation) File Number) Identification)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 542-2800
________________________________________________________________________________
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
The U.S. Patent and Trademark office has issued Osteotech, Inc. (the
"Company") U.S. Patent #5702677 entitled "Spherical Hydroxyapatite Particles and
Process for the Production Thereof" (the "Patent").
The Patent covers a process for producing spherical, non-porous
Hydroxyapatite (ceramic) particles which do not exceed 250 microns and have a
density of at least 3 grams per cc. These particles have a variety of
orthopaedic and dental applications and are ideally suited for soft tissue
augmentation.
In November, 1997, the Company's European subsidiary, CAM Implants, BV,
signed a long-term agreement to be the exclusive supplier to ConvaTec, a
Bristol Myers Squibb division, of calcium hydroxyapatite medical grade granules
utilizing the technology covered by the Patent. The granules are to be a key
component in ConvaTec's urethral sphincter augmentation device which is
currently in clinical trials in Europe and the United States. ConvaTec expects
to begin marketing its product in 1999/2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: January 16, 1998
OSTEOTECH, INC. (Registrant)
By:/s/ MICHAEL J. JEFFRIES
-----------------------------
Michael J. Jeffries
Executive Vice President, Chief
Operating Officer and Chief Financial
Officer (Principal Financial Officer and
Principal Accounting Officer)
